Informa helps businesses and professionals in hundreds of ways.

Our international portfolio of live events, world-leading research publications, and innovative digital services provide specialists with the knowledge and connections they need to thrive.

Antibody Engineering & Therapeutics Europe
1 - 3 June, 2027
Congress CenterBasel Switzerland
Menu

Dr. Chantal Hargreaves, PhD
Director, Drug Discovery at Nucleome Therapeutics
Speaker

Profile

Chantal Hargreaves received her PhD from King’s College London, studying the role of somatic hypermutation in anti‑thyroid antibody generation. She completed postdoctoral research at the Universities of Southampton and Oxford, focusing on Fc gamma receptor genetics, cancer immunotherapy responses, and primary antibody deficiency. Chantal joined Nucleome Therapeutics in 2021 and is now Director in the Drug Discovery group.

Agenda Sessions

  • 3D Genomics with Precision at Scale Has Solved the Challenge of Discovering Disease Targets from Human Genetics

    , 10:50
    View Session

At this event

Prev
Next
Niccolo Pengo, PhD
Chief Scientific Officer
Mabylon AG

See Chantal at Antibody Engineering & Therapeutics Europe